INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Dec 20, 2016 |
Director, Chairman of the Board
Trans History: 742
|
Director, Chairman of the Board | Form 4 | Other acquisition or disposition | -- | -- | 151,825 |
| Dec 20, 2016 |
Director, Chairman of the Board
Trans History: 742
|
Director, Chairman of the Board | Form 4 | Other acquisition or disposition | -- | -- | 92,947 |
| Dec 20, 2016 |
Director, Chairman of the Board
Trans History: 742
|
Director, Chairman of the Board | Form 4 | Other acquisition or disposition | -- | -- | 1,203 |
| Dec 19, 2016 |
SVP Clinical Development & Reg
Trans History: 208
|
SVP Clinical Development & Reg | Form 4 | Other acquisition or disposition | -- | -- | 25,714 |
| Dec 19, 2016 |
SVP Clinical Development & Reg
Trans History: 208
|
SVP Clinical Development & Reg | Form 4 | Other acquisition or disposition | -- | -- | 1,674 |
| Dec 19, 2016 |
Director, President & CEO
Trans History: 404
|
Director, President & CEO | Form 4 | Other acquisition or disposition | -- | -- | 5,702 |
| Dec 19, 2016 |
Director, President Regeneron Laboratori
Trans History: 628
|
Director, President Regeneron Laboratori | Form 4 | Other acquisition or disposition | -- | -- | 5,676 |
| Nov 09, 2016 |
Director, Chairman of the Board
Trans History: 742
|
Director, Chairman of the Board | Form 4 | Other acquisition or disposition | -- | -- | 2,290 |
| Nov 09, 2016 |
Director, Chairman of the Board
Trans History: 742
|
Director, Chairman of the Board | Form 4 | Other acquisition or disposition | -- | -- | 92,947 |
| Nov 09, 2016 |
Director, Chairman of the Board
Trans History: 742
|
Director, Chairman of the Board | Form 4 | Other acquisition or disposition | -- | -- | 1,203 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.